Jeff KnoxAug 84 minWhy We InvestedWhy We Invested - Persist.AISummary In drug development, new molecular entities get all the press. That’s largely justified – new molecules mean new medicines and...
Jeff KnoxJun 144 minWhy We InvestedWhy We Invested: AntiverseEven before Generative AI caught fire, computationally aided drug discovery was an area of intense interest for researchers. It should...
Mark LegareApr 115 minWhy We InvestedPortfolio Highlight - Our Investment in Voda.AICertain industries match well with certain founder profiles. A statement as equally true as it is banal. Within the vast domain ...